Ekso Bionics to Participate at Centers for Medicare & Medicaid Services (CMS) Second Biannual 2023 Healthcare Common Procedure Coding System (HCPCS) Public Meeting on Wednesday, November 29
16. November 2023 16:05 ET
|
Ekso Bionics Holdings, Inc.
SAN RAFAEL, Calif., Nov. 16, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today...
Centers for Medicare & Medicaid Services (CMS) Codifies Medicare Coverage for Ekso Indego Personal
02. November 2023 16:01 ET
|
Ekso Bionics Holdings, Inc.
Ruling Could Significantly Expand Use of Ekso Indego Personal in Home and Community Markets SAN RAFAEL, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the...
Ekso Bionics Reports Third Quarter 2023 Revenue Growth of 38%
26. Oktober 2023 16:05 ET
|
Ekso Bionics Holdings, Inc.
SAN RAFAEL, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today...
Ekso Bionics to Report Third Quarter 2023 Financial Results on October 26, 2023
19. Oktober 2023 16:05 ET
|
Ekso Bionics Holdings, Inc.
SAN RAFAEL, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today...
Ekso Bionics Supports Centers for Medicare & Medicaid Services (CMS) Proposed Rule to Include Personal Exoskeletons within a Medicare Benefit Category
27. September 2023 08:00 ET
|
Ekso Bionics Holdings, Inc.
SAN RAFAEL, Calif., Sept. 27, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use,...
Ekso Bionics to Participate at the H.C. Wainwright 25th Annual Global Investment Conference
11. September 2023 08:00 ET
|
Ekso Bionics Holdings, Inc.
SAN RAFAEL, Calif., Sept. 11, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today...
Ekso Bionics Reports Record Revenues of $4.7 Million in Second Quarter 2023
27. Juli 2023 16:05 ET
|
Ekso Bionics Holdings, Inc.
SAN RAFAEL, Calif., July 27, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today...
Ekso Bionics to Report Second Quarter 2023 Financial Results on July 27, 2023
20. Juli 2023 08:00 ET
|
Ekso Bionics Holdings, Inc.
SAN RAFAEL, Calif., July 20, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company” or “Ekso Bionics”), an industry leader in exoskeleton technology for medical and...
Ekso Bionics Announces 61% Increase in First Quarter 2023 Revenues
27. April 2023 16:05 ET
|
Ekso Bionics Holdings, Inc.
Highest Quarterly Revenues in Company History SAN RAFAEL, Calif., April 27, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company” or “Ekso Bionics”), an industry leader...
Ekso Bionics to Report First Quarter 2023 Financial Results on April 27, 2023
20. April 2023 08:00 ET
|
Ekso Bionics Holdings, Inc.
SAN RAFAEL, Calif., April 20, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today...